https://interactions.guidetherapeutiquevih.com/en/interaction-details?id=16417
Document made available to the pharmacist to communicate a drug interaction to the doctor.
DOWNLOADSofosbuvir / Velpatasvir can inhibit BCRP and increase the plasma concentration of Simvastatin.
–
–
–
Possible increase of adverse effects.
Use this combination with caution.
Use the lowest effective dose and titrate according to clinical response and occurrence of adverse effects.
Monitor closely.
–
Symptoms of toxicity associated with hypolipidemic agents : gastrointestinal effects, fatigue and muscular weaknesses, myalgias, muscular cramps, myopathies, rhabdomyolysis and myoglobinuria leading to renal insufficiency.
CK
Lipidic profile
–
–
–